Annual Consultation between the GPEI and poliovaccine manufacturers, National Authorities for Containment and National Regulatory Authorities


Annual Consultation between the GPEI and poliovaccine manufacturers, National Authorities for Containment and National Regulatory Authorities


Polio vaccines have saved millions from paralytic polio and banished poliovirus from almost all corners of the world. With eradication within reach, ensuring vaccine security is more critical than ever—not only to achieve this historic milestone but to sustain a polio-free world indefinitely.

On 23 October 2024, the Global Polio Eradication Initiative (GPEI) held its annual consultation with polio vaccine manufacturers, national regulatory authorities, and national authorities of containment. This gathering focused on strategies to secure the supply and optimal use of polio vaccines.

Nearly 300 participants, from 23 countries, attended the consultation, either in person or online. Together, they explored the opportunities and obstacles in polio vaccine development and production. They discussed the plans and processes that are being developed to secure the timely, sustained and uninterrupted supply of suitable affordable, quality assured polio vaccines to eradication and beyond.

After opening remarks from Dr Mike Ryan, Deputy Director-General of WHO, participants focused their deliberations on five key topics: progress in polio eradication, strategic frameworks for vaccine security, vaccine supply and demand, new products and innovations, and containment and certification. As part of this year’s consultation, several vaccine manufacturers also presented their experiences on new tools and technologies for polio eradication.

This report presents a summary of the presentations and discussions held during the consultation.

Share

Copied